| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9362945 | Otolaryngology - Head and Neck Surgery | 2005 | 8 Pages |
Abstract
These data suggest that the novel C6-Pyr-Cer with high solubility and bioavailability may lead to the development of new therapeutic strategies that target telomerase for the treatment of HNSCC.
Related Topics
Health Sciences
Medicine and Dentistry
Otorhinolaryngology and Facial Plastic Surgery
Authors
Michael J. MD, Kamala MS, Serap MD2, Monique S. BS, Zdzislaw M. PhD, Alicja PhD, Terry A. MD, Lina M. MD, Yusuf A. MD, Besim PhD,